Document Detail


Lupus myocarditis: marked improvement in cardiac function after intravenous immunoglobulin therapy.
MedLine Citation:
PMID:  19697032     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Intravenous immunoglobulin (IVIg) is emerging as the mainstay in the treatment of many autoimmune diseases, including systemic lupus erythematosus. IVIg has been found to be beneficial in myocarditis due to dermatomyositis/polymyositis, Kawasaki disease, and viral myocarditis in children. We report an 18-year-old man of active lupus with worsening cardiac systolic function who did not respond to pulse methylprednisolone and cyclophosphamide, but subsequently showed an improvement in his cardiac function after IVIg administration.
Authors:
Vikas Suri; Subhash Varma; Kiran Joshi; Pankaj Malhotra; Savita Kumari; Sanjay Jain
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2009-08-21
Journal Detail:
Title:  Rheumatology international     Volume:  30     ISSN:  1437-160X     ISO Abbreviation:  Rheumatol. Int.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8206885     Medline TA:  Rheumatol Int     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1503-5     Citation Subset:  IM    
Affiliation:
Post Graduate Institute of Medical Eduction and Research, Chandigarh, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Co-administration of irinotecan decreases the plasma concentration of an active metabolite of amrubi...
Next Document:  Atrial myxoma with metastasis misdiagnosed as Takayasu arteritis.